Mirror Therapy Integrated with Electrical Stimulation for Cortical Modulations
Launched by CHANG GUNG MEMORIAL HOSPITAL · Jan 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new approach to help people with peripheral nerve injuries, which can cause loss of feeling and movement in the hands. Researchers want to see how combining mirror therapy (a technique where patients use a mirror to visualize movement in their injured hand) with electrical stimulation can improve brain activity and recovery. By doing this, they hope to find better ways to support healing and improve patients' quality of life.
To participate in the trial, individuals must have recently been diagnosed with a specific type of nerve injury in the forearm, and they should be able to communicate in Chinese and follow instructions. Participants will likely be those who have noticeable muscle weakness in their injured hand. Throughout the study, they can expect to engage in therapies that may help improve their condition while contributing to important research on nerve recovery. If you or someone you know fits these criteria and is interested, it could be a chance to help advance treatment options for nerve injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • newly diagnosed median or ulnar nerve transection injury of the forearm in the past 6 months
- • sufficient communication in the Chinese language
- • being able to follow instructions
- • muscle atrophy or lack of voluntary contraction over the injured hand, with maximum voluntary isometric contraction (MVIC) recorded with surface electromyography (EMG) less than 10% compared to the non-affected hand
- • achieve an average score of 2 or above in the Kinesthetic and Visual Imagery Questionnaire-10 (KVIQ-10) for kinesthetic imagery
- Exclusion Criteria:
- • had central nervous disease
- • had a recent (1 year) history of nerve entrapment syndrome
- • had a history of latent neuropathy, such as diabetes or dialysis
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taoyuan, , Taiwan
Taipei, , Taiwan
Patients applied
Trial Officials
Yueh-Hsia Chen, PhD
Principal Investigator
National Taiwan University, School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported